ACRO BIOMEDICAL CO., LTD. (ACBM) › Operating Cash FlowACRO BIOMEDICAL CO., LTD. (ACBM) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2017: -$463.3K2018: -$140.4K2019: -$59.7K2020: -$199.5K2021: $299.3K2022: -$147.5K2023: -$15.4K2024: -$36.7K2025: -$196.3K-$196.3K2017Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$196.3K-435.0%2024-$36.7K-137.6%2023-$15.4K+89.5%2022-$147.5K-149.3%2021$299.3K+250.1%2020-$199.5K-234.1%2019-$59.7K+57.5%2018-$140.4K+69.7%2017-$463.3K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share